Skip to main content
Journal cover image

Nebivolol in older adults with heart failure: reduced rates for seniors?

Publication ,  Journal Article
Armstrong, PW; Alexander, KP
Published in: J Am Coll Cardiol
June 9, 2009

Duke Scholars

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

June 9, 2009

Volume

53

Issue

23

Start / End Page

2159 / 2161

Location

United States

Related Subject Headings

  • Stroke Volume
  • Nebivolol
  • Humans
  • Heart Failure
  • Ethanolamines
  • Cardiovascular System & Hematology
  • Benzopyrans
  • Antihypertensive Agents
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin II Type 1 Receptor Blockers
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Armstrong, P. W., & Alexander, K. P. (2009). Nebivolol in older adults with heart failure: reduced rates for seniors? J Am Coll Cardiol, 53(23), 2159–2161. https://doi.org/10.1016/j.jacc.2009.03.019
Armstrong, Paul W., and Karen P. Alexander. “Nebivolol in older adults with heart failure: reduced rates for seniors?J Am Coll Cardiol 53, no. 23 (June 9, 2009): 2159–61. https://doi.org/10.1016/j.jacc.2009.03.019.
Armstrong PW, Alexander KP. Nebivolol in older adults with heart failure: reduced rates for seniors? J Am Coll Cardiol. 2009 Jun 9;53(23):2159–61.
Armstrong, Paul W., and Karen P. Alexander. “Nebivolol in older adults with heart failure: reduced rates for seniors?J Am Coll Cardiol, vol. 53, no. 23, June 2009, pp. 2159–61. Pubmed, doi:10.1016/j.jacc.2009.03.019.
Armstrong PW, Alexander KP. Nebivolol in older adults with heart failure: reduced rates for seniors? J Am Coll Cardiol. 2009 Jun 9;53(23):2159–2161.
Journal cover image

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

June 9, 2009

Volume

53

Issue

23

Start / End Page

2159 / 2161

Location

United States

Related Subject Headings

  • Stroke Volume
  • Nebivolol
  • Humans
  • Heart Failure
  • Ethanolamines
  • Cardiovascular System & Hematology
  • Benzopyrans
  • Antihypertensive Agents
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin II Type 1 Receptor Blockers